nodes	percent_of_prediction	percent_of_DWPC	metapath
Levomilnacipran—CYP2C19—Esomeprazole—Barrett's esophagus	0.19	0.251	CbGbCtD
Levomilnacipran—CYP2C8—Omeprazole—Barrett's esophagus	0.133	0.176	CbGbCtD
Levomilnacipran—CYP2C19—Omeprazole—Barrett's esophagus	0.112	0.148	CbGbCtD
Levomilnacipran—CYP3A4—Esomeprazole—Barrett's esophagus	0.0918	0.121	CbGbCtD
Levomilnacipran—ABCB1—Omeprazole—Barrett's esophagus	0.0903	0.119	CbGbCtD
Levomilnacipran—CYP2D6—Omeprazole—Barrett's esophagus	0.0851	0.113	CbGbCtD
Levomilnacipran—CYP3A4—Omeprazole—Barrett's esophagus	0.0541	0.0715	CbGbCtD
Levomilnacipran—Testicular pain—Esomeprazole—Barrett's esophagus	0.0101	0.0451	CcSEcCtD
Levomilnacipran—Testicular pain—Omeprazole—Barrett's esophagus	0.0101	0.0451	CcSEcCtD
Levomilnacipran—Proteinuria—Esomeprazole—Barrett's esophagus	0.00271	0.0121	CcSEcCtD
Levomilnacipran—Aggression—Esomeprazole—Barrett's esophagus	0.00271	0.0121	CcSEcCtD
Levomilnacipran—Aggression—Omeprazole—Barrett's esophagus	0.00271	0.0121	CcSEcCtD
Levomilnacipran—Proteinuria—Omeprazole—Barrett's esophagus	0.00271	0.0121	CcSEcCtD
Levomilnacipran—Protein urine present—Esomeprazole—Barrett's esophagus	0.00267	0.0119	CcSEcCtD
Levomilnacipran—Protein urine present—Omeprazole—Barrett's esophagus	0.00267	0.0119	CcSEcCtD
Levomilnacipran—Gastrooesophageal reflux disease—Omeprazole—Barrett's esophagus	0.00264	0.0118	CcSEcCtD
Levomilnacipran—Gastrooesophageal reflux disease—Esomeprazole—Barrett's esophagus	0.00264	0.0118	CcSEcCtD
Levomilnacipran—Blood pressure increased—Esomeprazole—Barrett's esophagus	0.00238	0.0106	CcSEcCtD
Levomilnacipran—Blood pressure increased—Omeprazole—Barrett's esophagus	0.00238	0.0106	CcSEcCtD
Levomilnacipran—Cystitis noninfective—Esomeprazole—Barrett's esophagus	0.00233	0.0104	CcSEcCtD
Levomilnacipran—Cystitis noninfective—Omeprazole—Barrett's esophagus	0.00233	0.0104	CcSEcCtD
Levomilnacipran—Cystitis—Esomeprazole—Barrett's esophagus	0.0023	0.0103	CcSEcCtD
Levomilnacipran—Cystitis—Omeprazole—Barrett's esophagus	0.0023	0.0103	CcSEcCtD
Levomilnacipran—Dry eye—Omeprazole—Barrett's esophagus	0.0022	0.00981	CcSEcCtD
Levomilnacipran—Dry eye—Esomeprazole—Barrett's esophagus	0.0022	0.00981	CcSEcCtD
Levomilnacipran—Bladder pain—Esomeprazole—Barrett's esophagus	0.00215	0.0096	CcSEcCtD
Levomilnacipran—Bladder pain—Omeprazole—Barrett's esophagus	0.00215	0.0096	CcSEcCtD
Levomilnacipran—CYP2J2—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.00205	0.107	CbGpPWpGaD
Levomilnacipran—Hot flush—Esomeprazole—Barrett's esophagus	0.00185	0.00824	CcSEcCtD
Levomilnacipran—Hot flush—Omeprazole—Barrett's esophagus	0.00185	0.00824	CcSEcCtD
Levomilnacipran—Menopausal symptoms—Esomeprazole—Barrett's esophagus	0.00183	0.00817	CcSEcCtD
Levomilnacipran—Menopausal symptoms—Omeprazole—Barrett's esophagus	0.00183	0.00817	CcSEcCtD
Levomilnacipran—Thirst—Omeprazole—Barrett's esophagus	0.00182	0.0081	CcSEcCtD
Levomilnacipran—Thirst—Esomeprazole—Barrett's esophagus	0.00182	0.0081	CcSEcCtD
Levomilnacipran—Hyponatraemia—Esomeprazole—Barrett's esophagus	0.00174	0.00774	CcSEcCtD
Levomilnacipran—Hyponatraemia—Omeprazole—Barrett's esophagus	0.00174	0.00774	CcSEcCtD
Levomilnacipran—Migraine—Esomeprazole—Barrett's esophagus	0.0017	0.00759	CcSEcCtD
Levomilnacipran—Migraine—Omeprazole—Barrett's esophagus	0.0017	0.00759	CcSEcCtD
Levomilnacipran—Irritability—Esomeprazole—Barrett's esophagus	0.00165	0.00736	CcSEcCtD
Levomilnacipran—Irritability—Omeprazole—Barrett's esophagus	0.00165	0.00736	CcSEcCtD
Levomilnacipran—Dry skin—Esomeprazole—Barrett's esophagus	0.00159	0.00707	CcSEcCtD
Levomilnacipran—Dry skin—Omeprazole—Barrett's esophagus	0.00159	0.00707	CcSEcCtD
Levomilnacipran—Breast disorder—Esomeprazole—Barrett's esophagus	0.00156	0.00697	CcSEcCtD
Levomilnacipran—Breast disorder—Omeprazole—Barrett's esophagus	0.00156	0.00697	CcSEcCtD
Levomilnacipran—Abdominal distension—Esomeprazole—Barrett's esophagus	0.0015	0.00671	CcSEcCtD
Levomilnacipran—Abdominal distension—Omeprazole—Barrett's esophagus	0.0015	0.00671	CcSEcCtD
Levomilnacipran—Angina pectoris—Esomeprazole—Barrett's esophagus	0.00146	0.00649	CcSEcCtD
Levomilnacipran—Angina pectoris—Omeprazole—Barrett's esophagus	0.00146	0.00649	CcSEcCtD
Levomilnacipran—Dysuria—Esomeprazole—Barrett's esophagus	0.0014	0.00623	CcSEcCtD
Levomilnacipran—Neutropenia—Esomeprazole—Barrett's esophagus	0.0014	0.00623	CcSEcCtD
Levomilnacipran—Dysuria—Omeprazole—Barrett's esophagus	0.0014	0.00623	CcSEcCtD
Levomilnacipran—Neutropenia—Omeprazole—Barrett's esophagus	0.0014	0.00623	CcSEcCtD
Levomilnacipran—Upper respiratory tract infection—Omeprazole—Barrett's esophagus	0.00139	0.00619	CcSEcCtD
Levomilnacipran—Upper respiratory tract infection—Esomeprazole—Barrett's esophagus	0.00139	0.00619	CcSEcCtD
Levomilnacipran—Pollakiuria—Omeprazole—Barrett's esophagus	0.00138	0.00615	CcSEcCtD
Levomilnacipran—Pollakiuria—Esomeprazole—Barrett's esophagus	0.00138	0.00615	CcSEcCtD
Levomilnacipran—Erectile dysfunction—Omeprazole—Barrett's esophagus	0.00138	0.00614	CcSEcCtD
Levomilnacipran—Erectile dysfunction—Esomeprazole—Barrett's esophagus	0.00138	0.00614	CcSEcCtD
Levomilnacipran—Weight decreased—Esomeprazole—Barrett's esophagus	0.00135	0.00603	CcSEcCtD
Levomilnacipran—Weight decreased—Omeprazole—Barrett's esophagus	0.00135	0.00603	CcSEcCtD
Levomilnacipran—CYP2J2—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.00134	0.0701	CbGpPWpGaD
Levomilnacipran—CYP2J2—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.00132	0.0692	CbGpPWpGaD
Levomilnacipran—Stevens-Johnson syndrome—Esomeprazole—Barrett's esophagus	0.00132	0.00589	CcSEcCtD
Levomilnacipran—Stevens-Johnson syndrome—Omeprazole—Barrett's esophagus	0.00132	0.00589	CcSEcCtD
Levomilnacipran—Urinary tract infection—Omeprazole—Barrett's esophagus	0.0013	0.00577	CcSEcCtD
Levomilnacipran—Urinary tract infection—Esomeprazole—Barrett's esophagus	0.0013	0.00577	CcSEcCtD
Levomilnacipran—Haematuria—Esomeprazole—Barrett's esophagus	0.00127	0.00566	CcSEcCtD
Levomilnacipran—Haematuria—Omeprazole—Barrett's esophagus	0.00127	0.00566	CcSEcCtD
Levomilnacipran—Hepatobiliary disease—Esomeprazole—Barrett's esophagus	0.00126	0.00562	CcSEcCtD
Levomilnacipran—Hepatobiliary disease—Omeprazole—Barrett's esophagus	0.00126	0.00562	CcSEcCtD
Levomilnacipran—Hepatitis—Esomeprazole—Barrett's esophagus	0.0012	0.00533	CcSEcCtD
Levomilnacipran—Hepatitis—Omeprazole—Barrett's esophagus	0.0012	0.00533	CcSEcCtD
Levomilnacipran—Hallucination—Omeprazole—Barrett's esophagus	0.00119	0.00531	CcSEcCtD
Levomilnacipran—Hypoaesthesia—Esomeprazole—Barrett's esophagus	0.00119	0.00531	CcSEcCtD
Levomilnacipran—Hypoaesthesia—Omeprazole—Barrett's esophagus	0.00119	0.00531	CcSEcCtD
Levomilnacipran—Hallucination—Esomeprazole—Barrett's esophagus	0.00119	0.00531	CcSEcCtD
Levomilnacipran—Urinary tract disorder—Omeprazole—Barrett's esophagus	0.00118	0.00527	CcSEcCtD
Levomilnacipran—Urinary tract disorder—Esomeprazole—Barrett's esophagus	0.00118	0.00527	CcSEcCtD
Levomilnacipran—Oedema peripheral—Esomeprazole—Barrett's esophagus	0.00118	0.00525	CcSEcCtD
Levomilnacipran—Oedema peripheral—Omeprazole—Barrett's esophagus	0.00118	0.00525	CcSEcCtD
Levomilnacipran—Connective tissue disorder—Esomeprazole—Barrett's esophagus	0.00118	0.00524	CcSEcCtD
Levomilnacipran—Connective tissue disorder—Omeprazole—Barrett's esophagus	0.00118	0.00524	CcSEcCtD
Levomilnacipran—Urethral disorder—Omeprazole—Barrett's esophagus	0.00117	0.00523	CcSEcCtD
Levomilnacipran—Urethral disorder—Esomeprazole—Barrett's esophagus	0.00117	0.00523	CcSEcCtD
Levomilnacipran—Erythema multiforme—Omeprazole—Barrett's esophagus	0.00113	0.00504	CcSEcCtD
Levomilnacipran—Erythema multiforme—Esomeprazole—Barrett's esophagus	0.00113	0.00504	CcSEcCtD
Levomilnacipran—Eye disorder—Esomeprazole—Barrett's esophagus	0.00112	0.00498	CcSEcCtD
Levomilnacipran—Eye disorder—Omeprazole—Barrett's esophagus	0.00112	0.00498	CcSEcCtD
Levomilnacipran—Flushing—Omeprazole—Barrett's esophagus	0.00111	0.00495	CcSEcCtD
Levomilnacipran—Flushing—Esomeprazole—Barrett's esophagus	0.00111	0.00495	CcSEcCtD
Levomilnacipran—CYP2J2—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.00109	0.0568	CbGpPWpGaD
Levomilnacipran—Mediastinal disorder—Omeprazole—Barrett's esophagus	0.00108	0.00481	CcSEcCtD
Levomilnacipran—Mediastinal disorder—Esomeprazole—Barrett's esophagus	0.00108	0.00481	CcSEcCtD
Levomilnacipran—Chills—Omeprazole—Barrett's esophagus	0.00107	0.00478	CcSEcCtD
Levomilnacipran—Chills—Esomeprazole—Barrett's esophagus	0.00107	0.00478	CcSEcCtD
Levomilnacipran—Mental disorder—Esomeprazole—Barrett's esophagus	0.00105	0.00467	CcSEcCtD
Levomilnacipran—Mental disorder—Omeprazole—Barrett's esophagus	0.00105	0.00467	CcSEcCtD
Levomilnacipran—Malnutrition—Esomeprazole—Barrett's esophagus	0.00104	0.00464	CcSEcCtD
Levomilnacipran—Malnutrition—Omeprazole—Barrett's esophagus	0.00104	0.00464	CcSEcCtD
Levomilnacipran—Flatulence—Esomeprazole—Barrett's esophagus	0.00103	0.00457	CcSEcCtD
Levomilnacipran—Flatulence—Omeprazole—Barrett's esophagus	0.00103	0.00457	CcSEcCtD
Levomilnacipran—Tension—Omeprazole—Barrett's esophagus	0.00102	0.00456	CcSEcCtD
Levomilnacipran—Tension—Esomeprazole—Barrett's esophagus	0.00102	0.00456	CcSEcCtD
Levomilnacipran—Dysgeusia—Omeprazole—Barrett's esophagus	0.00102	0.00455	CcSEcCtD
Levomilnacipran—Dysgeusia—Esomeprazole—Barrett's esophagus	0.00102	0.00455	CcSEcCtD
Levomilnacipran—Vision blurred—Omeprazole—Barrett's esophagus	0.000982	0.00437	CcSEcCtD
Levomilnacipran—Vision blurred—Esomeprazole—Barrett's esophagus	0.000982	0.00437	CcSEcCtD
Levomilnacipran—Tremor—Esomeprazole—Barrett's esophagus	0.000976	0.00435	CcSEcCtD
Levomilnacipran—Tremor—Omeprazole—Barrett's esophagus	0.000976	0.00435	CcSEcCtD
Levomilnacipran—Agitation—Omeprazole—Barrett's esophagus	0.000957	0.00427	CcSEcCtD
Levomilnacipran—Agitation—Esomeprazole—Barrett's esophagus	0.000957	0.00427	CcSEcCtD
Levomilnacipran—Leukopenia—Esomeprazole—Barrett's esophagus	0.000932	0.00416	CcSEcCtD
Levomilnacipran—Leukopenia—Omeprazole—Barrett's esophagus	0.000932	0.00416	CcSEcCtD
Levomilnacipran—Palpitations—Esomeprazole—Barrett's esophagus	0.00092	0.0041	CcSEcCtD
Levomilnacipran—Palpitations—Omeprazole—Barrett's esophagus	0.00092	0.0041	CcSEcCtD
Levomilnacipran—Hypertension—Esomeprazole—Barrett's esophagus	0.000899	0.00401	CcSEcCtD
Levomilnacipran—Hypertension—Omeprazole—Barrett's esophagus	0.000899	0.00401	CcSEcCtD
Levomilnacipran—Chest pain—Omeprazole—Barrett's esophagus	0.000887	0.00395	CcSEcCtD
Levomilnacipran—Chest pain—Esomeprazole—Barrett's esophagus	0.000887	0.00395	CcSEcCtD
Levomilnacipran—Anxiety—Omeprazole—Barrett's esophagus	0.000884	0.00394	CcSEcCtD
Levomilnacipran—Anxiety—Esomeprazole—Barrett's esophagus	0.000884	0.00394	CcSEcCtD
Levomilnacipran—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.000881	0.00392	CcSEcCtD
Levomilnacipran—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.000881	0.00392	CcSEcCtD
Levomilnacipran—Dry mouth—Esomeprazole—Barrett's esophagus	0.000867	0.00387	CcSEcCtD
Levomilnacipran—Dry mouth—Omeprazole—Barrett's esophagus	0.000867	0.00387	CcSEcCtD
Levomilnacipran—Infection—Esomeprazole—Barrett's esophagus	0.000844	0.00376	CcSEcCtD
Levomilnacipran—Infection—Omeprazole—Barrett's esophagus	0.000844	0.00376	CcSEcCtD
Levomilnacipran—Shock—Omeprazole—Barrett's esophagus	0.000836	0.00373	CcSEcCtD
Levomilnacipran—Shock—Esomeprazole—Barrett's esophagus	0.000836	0.00373	CcSEcCtD
Levomilnacipran—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.000834	0.00372	CcSEcCtD
Levomilnacipran—Nervous system disorder—Omeprazole—Barrett's esophagus	0.000834	0.00372	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Esomeprazole—Barrett's esophagus	0.000832	0.00371	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Omeprazole—Barrett's esophagus	0.000832	0.00371	CcSEcCtD
Levomilnacipran—Tachycardia—Esomeprazole—Barrett's esophagus	0.00083	0.0037	CcSEcCtD
Levomilnacipran—Tachycardia—Omeprazole—Barrett's esophagus	0.00083	0.0037	CcSEcCtD
Levomilnacipran—Skin disorder—Omeprazole—Barrett's esophagus	0.000826	0.00368	CcSEcCtD
Levomilnacipran—Skin disorder—Esomeprazole—Barrett's esophagus	0.000826	0.00368	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Esomeprazole—Barrett's esophagus	0.000822	0.00366	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Omeprazole—Barrett's esophagus	0.000822	0.00366	CcSEcCtD
Levomilnacipran—Anorexia—Omeprazole—Barrett's esophagus	0.00081	0.00361	CcSEcCtD
Levomilnacipran—Anorexia—Esomeprazole—Barrett's esophagus	0.00081	0.00361	CcSEcCtD
Levomilnacipran—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.000799	0.0418	CbGpPWpGaD
Levomilnacipran—Insomnia—Esomeprazole—Barrett's esophagus	0.000769	0.00343	CcSEcCtD
Levomilnacipran—Insomnia—Omeprazole—Barrett's esophagus	0.000769	0.00343	CcSEcCtD
Levomilnacipran—Paraesthesia—Omeprazole—Barrett's esophagus	0.000763	0.0034	CcSEcCtD
Levomilnacipran—Paraesthesia—Esomeprazole—Barrett's esophagus	0.000763	0.0034	CcSEcCtD
Levomilnacipran—Dyspnoea—Esomeprazole—Barrett's esophagus	0.000758	0.00338	CcSEcCtD
Levomilnacipran—Dyspnoea—Omeprazole—Barrett's esophagus	0.000758	0.00338	CcSEcCtD
Levomilnacipran—Somnolence—Omeprazole—Barrett's esophagus	0.000756	0.00337	CcSEcCtD
Levomilnacipran—Somnolence—Esomeprazole—Barrett's esophagus	0.000756	0.00337	CcSEcCtD
Levomilnacipran—Dyspepsia—Omeprazole—Barrett's esophagus	0.000748	0.00333	CcSEcCtD
Levomilnacipran—Dyspepsia—Esomeprazole—Barrett's esophagus	0.000748	0.00333	CcSEcCtD
Levomilnacipran—Decreased appetite—Omeprazole—Barrett's esophagus	0.000739	0.00329	CcSEcCtD
Levomilnacipran—Decreased appetite—Esomeprazole—Barrett's esophagus	0.000739	0.00329	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.000734	0.00327	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.000734	0.00327	CcSEcCtD
Levomilnacipran—Fatigue—Esomeprazole—Barrett's esophagus	0.000733	0.00327	CcSEcCtD
Levomilnacipran—Fatigue—Omeprazole—Barrett's esophagus	0.000733	0.00327	CcSEcCtD
Levomilnacipran—Constipation—Omeprazole—Barrett's esophagus	0.000727	0.00324	CcSEcCtD
Levomilnacipran—Constipation—Esomeprazole—Barrett's esophagus	0.000727	0.00324	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.000695	0.0031	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.000695	0.0031	CcSEcCtD
Levomilnacipran—Urticaria—Omeprazole—Barrett's esophagus	0.000675	0.00301	CcSEcCtD
Levomilnacipran—Urticaria—Esomeprazole—Barrett's esophagus	0.000675	0.00301	CcSEcCtD
Levomilnacipran—Abdominal pain—Esomeprazole—Barrett's esophagus	0.000672	0.00299	CcSEcCtD
Levomilnacipran—Body temperature increased—Esomeprazole—Barrett's esophagus	0.000672	0.00299	CcSEcCtD
Levomilnacipran—Abdominal pain—Omeprazole—Barrett's esophagus	0.000672	0.00299	CcSEcCtD
Levomilnacipran—Body temperature increased—Omeprazole—Barrett's esophagus	0.000672	0.00299	CcSEcCtD
Levomilnacipran—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.000626	0.00279	CcSEcCtD
Levomilnacipran—Hypersensitivity—Omeprazole—Barrett's esophagus	0.000626	0.00279	CcSEcCtD
Levomilnacipran—Asthenia—Omeprazole—Barrett's esophagus	0.00061	0.00272	CcSEcCtD
Levomilnacipran—Asthenia—Esomeprazole—Barrett's esophagus	0.00061	0.00272	CcSEcCtD
Levomilnacipran—Pruritus—Esomeprazole—Barrett's esophagus	0.000601	0.00268	CcSEcCtD
Levomilnacipran—Pruritus—Omeprazole—Barrett's esophagus	0.000601	0.00268	CcSEcCtD
Levomilnacipran—Diarrhoea—Esomeprazole—Barrett's esophagus	0.000582	0.00259	CcSEcCtD
Levomilnacipran—Diarrhoea—Omeprazole—Barrett's esophagus	0.000582	0.00259	CcSEcCtD
Levomilnacipran—CYP2J2—Biological oxidations—CYP26A1—Barrett's esophagus	0.000577	0.0302	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000569	0.0298	CbGpPWpGaD
Levomilnacipran—Dizziness—Omeprazole—Barrett's esophagus	0.000562	0.00251	CcSEcCtD
Levomilnacipran—Dizziness—Esomeprazole—Barrett's esophagus	0.000562	0.00251	CcSEcCtD
Levomilnacipran—Vomiting—Omeprazole—Barrett's esophagus	0.00054	0.00241	CcSEcCtD
Levomilnacipran—Vomiting—Esomeprazole—Barrett's esophagus	0.00054	0.00241	CcSEcCtD
Levomilnacipran—Rash—Omeprazole—Barrett's esophagus	0.000536	0.00239	CcSEcCtD
Levomilnacipran—Rash—Esomeprazole—Barrett's esophagus	0.000536	0.00239	CcSEcCtD
Levomilnacipran—Dermatitis—Omeprazole—Barrett's esophagus	0.000535	0.00239	CcSEcCtD
Levomilnacipran—Dermatitis—Esomeprazole—Barrett's esophagus	0.000535	0.00239	CcSEcCtD
Levomilnacipran—Headache—Esomeprazole—Barrett's esophagus	0.000533	0.00237	CcSEcCtD
Levomilnacipran—Headache—Omeprazole—Barrett's esophagus	0.000533	0.00237	CcSEcCtD
Levomilnacipran—CYP2C8—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000511	0.0267	CbGpPWpGaD
Levomilnacipran—Nausea—Omeprazole—Barrett's esophagus	0.000505	0.00225	CcSEcCtD
Levomilnacipran—Nausea—Esomeprazole—Barrett's esophagus	0.000505	0.00225	CcSEcCtD
Levomilnacipran—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.000492	0.0258	CbGpPWpGaD
Levomilnacipran—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000459	0.024	CbGpPWpGaD
Levomilnacipran—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000459	0.024	CbGpPWpGaD
Levomilnacipran—CYP2C19—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000456	0.0239	CbGpPWpGaD
Levomilnacipran—SLC6A4—Circadian rythm related genes—CRTC1—Barrett's esophagus	0.000422	0.0221	CbGpPWpGaD
Levomilnacipran—CYP2J2—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.000401	0.021	CbGpPWpGaD
Levomilnacipran—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000334	0.0175	CbGpPWpGaD
Levomilnacipran—CYP2C8—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.00033	0.0173	CbGpPWpGaD
Levomilnacipran—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000299	0.0156	CbGpPWpGaD
Levomilnacipran—ABCB1—HIF-1-alpha transcription factor network—MCL1—Barrett's esophagus	0.000295	0.0154	CbGpPWpGaD
Levomilnacipran—CYP2C19—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000295	0.0154	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000292	0.0153	CbGpPWpGaD
Levomilnacipran—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000283	0.0148	CbGpPWpGaD
Levomilnacipran—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000283	0.0148	CbGpPWpGaD
Levomilnacipran—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000275	0.0144	CbGpPWpGaD
Levomilnacipran—CYP2C8—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000271	0.0142	CbGpPWpGaD
Levomilnacipran—CYP2D6—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000271	0.0142	CbGpPWpGaD
Levomilnacipran—CYP2C19—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000242	0.0127	CbGpPWpGaD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—SST—Barrett's esophagus	0.000231	0.0121	CbGpPWpGaD
Levomilnacipran—CYP2D6—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000223	0.0116	CbGpPWpGaD
Levomilnacipran—CYP3A4—Irinotecan Pathway—APC—Barrett's esophagus	0.000196	0.0103	CbGpPWpGaD
Levomilnacipran—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.00018	0.00939	CbGpPWpGaD
Levomilnacipran—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000177	0.00927	CbGpPWpGaD
Levomilnacipran—SLC6A4—NRF2 pathway—HGF—Barrett's esophagus	0.000173	0.00908	CbGpPWpGaD
Levomilnacipran—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000151	0.0079	CbGpPWpGaD
Levomilnacipran—SLC6A2—NRF2 pathway—HGF—Barrett's esophagus	0.000149	0.00781	CbGpPWpGaD
Levomilnacipran—SLC6A2—SLC-mediated transmembrane transport—SLC9A1—Barrett's esophagus	0.000148	0.00772	CbGpPWpGaD
Levomilnacipran—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000146	0.00762	CbGpPWpGaD
Levomilnacipran—CYP2C8—Biological oxidations—CYP26A1—Barrett's esophagus	0.000144	0.00754	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000142	0.00743	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—PTGES—Barrett's esophagus	0.00013	0.00681	CbGpPWpGaD
Levomilnacipran—CYP2C19—Biological oxidations—CYP26A1—Barrett's esophagus	0.000129	0.00673	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000127	0.00663	CbGpPWpGaD
Levomilnacipran—SLC6A2—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000122	0.0064	CbGpPWpGaD
Levomilnacipran—CYP2D6—Biological oxidations—CYP26A1—Barrett's esophagus	0.000118	0.00619	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000117	0.0061	CbGpPWpGaD
Levomilnacipran—CYP2C8—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.0001	0.00524	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—CYP26A1—Barrett's esophagus	9.87e-05	0.00516	CbGpPWpGaD
Levomilnacipran—SLC6A4—Circadian rythm related genes—PPARG—Barrett's esophagus	9.63e-05	0.00504	CbGpPWpGaD
Levomilnacipran—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	9.31e-05	0.00487	CbGpPWpGaD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—CXCL8—Barrett's esophagus	9e-05	0.00471	CbGpPWpGaD
Levomilnacipran—CYP2C19—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	8.94e-05	0.00468	CbGpPWpGaD
Levomilnacipran—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	7.73e-05	0.00405	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	7.63e-05	0.00399	CbGpPWpGaD
Levomilnacipran—SLC6A2—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	7.5e-05	0.00392	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	7.3e-05	0.00382	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	7.29e-05	0.00381	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—SLC9A1—Barrett's esophagus	7.11e-05	0.00372	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	6.51e-05	0.00341	CbGpPWpGaD
Levomilnacipran—ABCB1—Allograft Rejection—CXCL8—Barrett's esophagus	5.87e-05	0.00307	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	5.74e-05	0.003	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	5.39e-05	0.00282	CbGpPWpGaD
Levomilnacipran—SLC6A4—Circadian rythm related genes—TP53—Barrett's esophagus	4.51e-05	0.00236	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	3.93e-05	0.00206	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	3.3e-05	0.00173	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PTGES—Barrett's esophagus	3.25e-05	0.0017	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—PPARG—Barrett's esophagus	3.25e-05	0.0017	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	2.99e-05	0.00156	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PTGES—Barrett's esophagus	2.9e-05	0.00152	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PTGES—Barrett's esophagus	2.83e-05	0.00148	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PTGES—Barrett's esophagus	2.67e-05	0.0014	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—PTGS2—Barrett's esophagus	2.55e-05	0.00134	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CYP26A1—Barrett's esophagus	2.46e-05	0.00129	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CYP26A1—Barrett's esophagus	2.2e-05	0.00115	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CYP26A1—Barrett's esophagus	2.15e-05	0.00112	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CYP26A1—Barrett's esophagus	2.02e-05	0.00106	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.82e-05	0.000952	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	1.78e-05	0.00093	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—SLC9A1—Barrett's esophagus	1.78e-05	0.000929	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PTGES—Barrett's esophagus	1.74e-05	0.000913	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.62e-05	0.00085	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—SLC9A1—Barrett's esophagus	1.58e-05	0.000829	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—SLC9A1—Barrett's esophagus	1.55e-05	0.000809	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—SLC9A1—Barrett's esophagus	1.46e-05	0.000763	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.43e-05	0.000749	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	1.32e-05	0.000692	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.28e-05	0.000669	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	9.53e-06	0.000499	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PPARG—Barrett's esophagus	8.11e-06	0.000424	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PPARG—Barrett's esophagus	7.23e-06	0.000379	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PPARG—Barrett's esophagus	7.06e-06	0.000369	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PPARG—Barrett's esophagus	6.65e-06	0.000348	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PTGS2—Barrett's esophagus	6.38e-06	0.000334	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PTGS2—Barrett's esophagus	5.69e-06	0.000298	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PTGS2—Barrett's esophagus	5.56e-06	0.000291	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PTGS2—Barrett's esophagus	5.23e-06	0.000274	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PPARG—Barrett's esophagus	4.35e-06	0.000228	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	3.42e-06	0.000179	CbGpPWpGaD
